BirchBioMed

About:

BirchBioMed is a clinical-stage biomedical company.

Top Investors: entrepreneurship@UBC, National Institute for Health Research

Description:

BirchBioMed is a clinical-stage biomedical company focused on the clinical evaluation. It specializes in development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded in 2015 and headquartered in King City, Ontario.

Total Funding Amount:

$5.3M

Headquarters Location:

King City, Ontario, Canada

Founded Date:

2015-01-01

Founders:

Mark Miller, Ryan Hartwell, Susan Elliott

Number of Employees:

1-10

Last Funding Date:

2016-05-20

IPO Status:

Private

Industries: